| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham serves as an EVP Research &Development at CYTK and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 109 sells. Those positions are worth an estimated $12.6M at current prices.
Historically, Malik Fady Ibraham's trades have earned a middling insider score of 55/100 across 77 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -29.7%.
The biggest single holding is CYTK (~$12.5M) as EVP Research &Development. The recent filings there lean toward selling, a net 574,726 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 29,166 | $36.49 | $1,064,287.76 | -8.9% | +8.8% | +2.1% | |
| Nov 11, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $39.56 | $79,120.00 | -1.3% | -1.0% | +0.4% | |
| Oct 14, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $37.73 | $75,452.20 | -1.3% | -10.5% | +20.5% | |
| Sep 9, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $31.43 | $62,860.00 | -1.3% | +23.3% | +81.4% | |
| Aug 12, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $32.60 | $65,200.00 | -1.3% | +21.8% | +55.1% | |
| Jul 8, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $19.48 | $38,952.20 | -1.3% | +83.1% | +135.7% | |
| Jun 10, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $21.48 | $42,951.60 | -1.2% | +44.6% | +83.6% | |
| May 13, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $24.42 | $48,840.00 | -1.2% | +28.9% | +66.5% | |
| Apr 8, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $23.39 | $46,772.40 | -1.2% | -18.3% | +72.3% | |
| Mar 11, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 2,000 | $19.90 | $39,798.00 | -1.2% | -11.4% | +54.4% |